Canton Strategic Holdings (CNTN) Cash from Operations (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Cash from Operations of 7635188.0 for Q1 2026, up 26.88% on a QoQ basis from 10441616.0 in Q4 2025, and down 183.94% year-over-year from 9095851.28 in Q1 2025.
Canton Strategic Holdings (CNTN) Cash from Operations (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Cash from Operations history runs 6 years deep, the most recent figure standing at 7635188.0 for Q1 2026.
- Quarterly Cash from Operations fell 183.94% year-over-year to 7635188.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21074503.0 (down 95.79% YoY) and the FY2025 annual result came in at 16128316.0, down 47.97% from the prior year.
- Cash from Operations was 7635188.0 for Q1 2026 at Canton Strategic Holdings, up from 10441616.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 892676.0 in Q4 2022 and bottomed at 10441616.0 in Q4 2025.
- A 5-year average of 2854209.41 and a median of 2179303.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 11530.96% — and 2025, when it soared 47.57%.
- Canton Strategic Holdings' Cash from Operations stood at 892676.0 in 2022, then plunged by 58.56% to 1415427.0 in 2023, then slumped by 114.19% to 3031656.0 in 2024, then plunged by 244.42% to 10441616.0 in 2025, then gained by 26.88% to 7635188.0 in 2026.
- Business Quant data shows CNTN's Cash from Operations at 7635188.0 in Q1 2026, 10441616.0 in Q4 2025, and 1855169.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Canton Strategic Holdings | 425.80 Mn | 425.80 Mn | - | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |